keking929
Shared posts
Perspectives: Giving credit where it is due
On-Demand Complex Peptide Synthesis: An Aspirational (and Elusive?) Goal for Peptide Synthesis
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth
Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery
Modulating Drug Release Rate from Partially Silica-Coated Bicellar Nanodisc by Incorporating PEGylated Phospholipid
A New Design Strategy and Diagnostic to Tailor the DNA-Binding Mechanism of Small Organic Molecules and Drugs
Roger Y. Tsien (1952–2016)
Roger Y. Tsien, professor at the University of California, San Diego and Howard Hughes Medical Institute Investigator, passed away on August 24, 2016. Tsien shared the 2008 Nobel Prize in Chemistry for his work on the discovery and development of the green fluorescent protein, and developed a whole series of colored fluorescent proteins, as well as widely used small-molecule probes for Ca2+ ions.
Improving the Intracellular Drug Concentration in Lung Cancer Treatment through the Codelivery of Doxorubicin and miR-519c Mediated by Porous PLGA Microparticle
Medicine Nobel for research on how cells 'eat themselves'
Medicine Nobel for research on how cells 'eat themselves'
Nature 538, 7623 (2016). http://www.nature.com/doifinder/10.1038/nature.2016.20721
Authors: Richard Van Noorden & Heidi Ledford
Japanese biologist Yoshinori Ohsumi recognized for work on autophagy.
9-Silafluorenyl Dichlorides as Chemically Ligating Coupling Agents and Their Application in Peptide Synthesis
Abstract
A fundamentally simple, mild, and practical procedure for peptide bond formation is reported that employs a stoichiometric amount of easy-to-access 9-silafluorenyl dichlorides as the coupling agent. Without initial preactivation or elaboration of the carboxylic acid or amine termini of the amino acids, the developed reagent is proposed to act through an unprecedented chemical ligation mechanism, bringing the two coupling partners together before being subsequently eliminated. The desired amides or peptide bonds are thus furnished in good yields and with low to no epimerization.
A chemical ligation mechanism was proposed for amide bond formation with 9-silafluorenyl dichlorides as new coupling reagents. This approach enabled the synthesis of peptides in a simple and unprecedented manner without preactivation of either the carboxylic acid or amine termini of the amino acids.
VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells
α-Helical coiled-coil peptide materials for biomedical applications
Self-assembling coiled coils, which occur commonly in native proteins, have received significant interest for the design of new biomaterials-based medical therapies. Considerable effort over recent years has led to a detailed understanding of the self-assembly process of coiled coils, and a diverse collection of strategies have been developed for designing functional materials using this motif. The ability to engineer the interface between coiled coils allows one to achieve variously connected components, leading to precisely defined structures such as nanofibers, nanotubes, nanoparticles, networks, gels, and combinations of these. Currently these materials are being developed for a range of biotechnological and medical applications, including drug delivery systems for controlled release, targeted nanomaterials, ‘drug-free’ therapeutics, vaccine delivery systems, and others. WIREs Nanomed Nanobiotechnol 2017, 9:e1424. doi: 10.1002/wnan.1424
For further resources related to this article, please visit the WIREs website.
Coiled coils are oligomerizing structures useful for designing nanomaterials such as particles, fibers, and networks within biomedical applications.
Unimolecular Micelles of Amphiphilic Cyclodextrin-Core Star-Like Copolymers with Covalent pH-Responsive Linkage of Anticancer Prodrugs
Straightforward Glycoengineering Approach to Site-Specific Antibody–Pyrrolobenzodiazepine Conjugates
Interfering with the Dimerization of the ErbB Receptors by Transmembrane Domain-Derived Peptides Inhibits Tumorigenic Growth in Vitro and in Vivo
Membrane targeting and insertion of the C-tail protein SciP.
Membrane targeting and insertion of the C-tail protein SciP.
J Mol Biol. 2016 Sep 3;
Authors: Pross E, Soussoula L, Seitl I, Lupo D, Kuhn A
Abstract
C-tailed membrane proteins insert into the bilayer post-translationally because the hydrophobic anchor segment leaves the ribosome at the end of translation. Nevertheless, we find here evidence that the targeting of SciP to the membrane of Escherichia coli occurs co-translationally since signal elements in the N-terminal part of the SciP protein sequence are present. Two short hydrophobic sequences were identified that targeted a GFP-SciP fusion protein to the membrane involving the signal recognition particle (SRP). After targeting, the membrane insertion of SciP is catalysed by YidC independently of the SecYEG translocase. However, when the C-terminal tail of SciP was extended to 21 amino acid residues we found that SecYEG becomes involved and makes its membrane insertion more efficient.
PMID: 27600410 [PubMed - as supplied by publisher]
Covalent Targeting of FGFR Inhibits Metastasis
Therapeutic targeting of late-stage breast cancer is limited by an inadequate understanding of how tumor cell signaling evolves during metastatic progression and by the currently available small molecule inhibitors capable of targeting these processes. Herein, we demonstrate that both β3 integrin and fibroblast growth factor receptor-1 (FGFR1) are part of an epithelial–mesenchymal transition (EMT) program that is required to facilitate metastatic outgrowth in response to fibroblast growth factor-2 (FGF2). Mechanistically, β3 integrin physically disrupts an interaction between FGFR1 and E-cadherin, leading to a dramatic redistribution of FGFR1 subcellular localization, enhanced FGF2 signaling and increased three-dimensional (3D) outgrowth of metastatic breast cancer cells. This ability of β3 integrin to drive FGFR signaling requires the enzymatic activity of focal adhesion kinase (FAK). Consistent with these mechanistic data, we demonstrate that FGFR, β3 integrin, and FAK constitute a molecular signature capable of predicting decreased survival of patients with the basal-like subtype of breast cancer. Importantly, covalent targeting of a conserved cysteine in the P-loop of FGFR1–4 with our newly developed small molecule, FIIN-4, more effectively blocks 3D metastatic outgrowth as compared with currently available FGFR inhibitors. In vivo application of FIIN-4 potently inhibited the growth of metastatic, patient-derived breast cancer xenografts and murine-derived metastases growing within the pulmonary microenvironment. Overall, the current studies demonstrate that FGFR1 works in concert with other EMT effector molecules to drive aberrant downstream signaling, and that these events can be effectively targeted using our novel therapeutics for the treatment of the most aggressive forms of breast cancer. Mol Cancer Ther; 15(9); 2096–106. ©2016 AACR.
Pathogenic cysteine removal mutations in FGFR extracellular domains stabilize receptor dimers and perturb the TM dimer structure.
Pathogenic cysteine removal mutations in FGFR extracellular domains stabilize receptor dimers and perturb the TM dimer structure.
J Mol Biol. 2016 Sep 2;
Authors: Sarabipour S, Hristova K
Abstract
Missense mutations which introduce or remove cysteine residues in receptor tyrosine kinases (RTKs) are believed to cause pathologies by stabilizing the active RTK dimers. However, the magnitude of this stabilizing effect has not been measured for full-length receptors. Here, we characterize the dimer stabilities of three full-length fibroblast growth factor (FGFR) mutants harboring pathogenic cysteine substitutions: the C178S FGFR1 mutant, the C342R FGFR2 mutant, and the C228R FGFR3 mutant. We find that the three mutations stabilize the FGFR dimers. We further see that the mutations alter the configuration of the FGFR transmembrane (TM) dimers. Thus, both aberrant dimerization and perturbed dimer structure likely contribute to the pathological phenotypes arising due to these mutations.
PMID: 27596331 [PubMed - as supplied by publisher]
Nobel Laureate Roger Tsien dies at 64
DEP-1 Promotes Angiogenesis, Permeability, and Metastasis
Antagonizing the Androgen Receptor with a Biomimetic Acyltransferase
Linker Immolation Determines Cell Killing Activity of Disulfide-Linked Pyrrolobenzodiazepine Antibody–Drug Conjugates
Enhancing Therapeutic Efficacy of Cisplatin by Blocking DNA Damage Repair
Well-Defined Polymer–Paclitaxel Prodrugs by a Grafting-from-Drug Approach
Abstract
We report on the design of a polymeric prodrug of the anticancer agent paclitaxel (PTX) by a grafting-from-drug approach. A chain transfer agent for reversible addition fragmentation chain transfer (RAFT) polymerization was efficiently and regioselectively linked to the C2′ position of paclitaxel, which is crucial for its bioactivity. Subsequent RAFT polymerization of a hydrophilic monomer yielded well-defined paclitaxel–polymer conjugates with high drug loading, water solubility, and stability. The versatility of this approach was further demonstrated by ω-end post-functionalization with a fluorescent tracer. In vitro experiments showed that these conjugates are readily taken up into endosomes where native PTX is efficiently cleaved off and then reaches its subcellular target. This was confirmed by the cytotoxicity profile of the conjugate, which matches those of commercial PTX formulations based on mere physical encapsulation.
Visible effects: Well-defined paclitaxel–polymer conjugates with high drug loading, water solubility, and stability were obtained by a grafting-from approach. They are readily taken up into endosomes where native paclitaxel is efficiently released. The versatility of this approach was further demonstrated by post-functionalization with a fluorescent tracer.
Overexpression of Antimicrobial, Anticancer, and Transmembrane Peptides in Escherichia coli through a Calmodulin-Peptide Fusion System
Virus-Inspired Polymer for Efficient In Vitro and In Vivo Gene Delivery
Abstract
Clinical translation of nucleic acids drugs has been stunted by limited delivery options. Herein, we report a synthetic polymer designed to mimic viral mechanisms of delivery called VIPER (virus-inspired polymer for endosomal release). VIPER is composed of a polycation block for condensation of nucleic acids, and a pH-sensitive block for acid-triggered display of a lytic peptide to promote trafficking to the cell cytosol. VIPER shows superior efficiencies compared to commercial agents when delivering genes to multiple immortalized cell lines. Importantly, in murine models, VIPER facilitates effective gene transfer to solid tumors.
A virus-inspired polymer is reported as an effective gene transfer vehicle. The polymer, called VIPER (virus-inspired polymer for endosomal release), is composed of a polycation block for nucleic acids condensation and a pH-sensitive block for acid-triggered display of a lytic peptide to promote trafficking to the cell cytosol both in vitro and in vivo.
PPII Helical Peptidomimetics Templated by Cation–π Interactions
Abstract
Poly-proline type II (PPII) helical PXXP motifs are the recognition elements for a variety of protein–protein interactions that are critical for cellular signaling. Despite development of protocols for locking peptides into α-helical and β-strand conformations, there remains a lack of analogous methods for generating mimics of PPII helical structures. We describe herein a strategy to enforce PPII helical secondary structure in the 19-residue TrpPlexus miniature protein. Through sequence variation, we showed that a network of cation–π interactions could drive the formation of PPII helical conformations for both peptide and N-substituted glycine peptoid residues. The achievement of chemically diverse PPII helical scaffolds provides a new route towards discovering peptidomimetic inhibitors of protein–protein interactions mediated by PXXP motifs.
PPII helices on lockdown: A network of cation–π interactions was used to template peptide and peptoid residues into left-handed poly-proline type II (PPII) helices, covalently locking the secondary structure with an engineered disulfide bridge. These chemically diverse PPII helical structures provide a new route toward peptidomimetic protein–protein interaction inhibitors.
















